COVID-19 Vaccination in Patients with Chronic Conditions

Welcome to the National COVID-19 Vaccine Research Study for Patients with Chronic Conditions

COVID-19 Antibody Testing of Patients with Chronic Conditions is being led by a team of researchers at Johns Hopkins Medicine. The principal investigator is Jacqueline Garonzik Wang, MD PhD, Associate Professor Of Surgery. The study has been approved by the Johns Hopkins Institutional Review Board (IRB00248540).

The purpose of this research study is to determine COVID-19 antibody levels in patients with chronic conditions who receive the COVID-19 vaccine. The study does not provide the vaccine, and study team members will not be offering guidance as to whether one should or should not receive the SARS-CoV-2 vaccine. If participants will be receiving a vaccine and are interested in the study, we will collect a sample before vaccination, and collect samples at sequential time points post-vaccination to determine antibody levels.

We are now enrolling patients for this observational study. For more information, click below or e-mail vaccineresponse@jhmi.edu.




Dorry Segev, MD, PhD | Jacqueline Garonzik-Wang, MD, PhD | | Julie Paik, MD | Lisa Christopher-Stine, MD | Robin Avery, MD | Douglas Mogul, MD, PhD | William Werbel, MD | Brian Boyarsky, MD | Caoilfhionn Connolly, MD

Copyright Johns Hopkins University, 2020 | Baltimore, MD 21205